Article Cited by others

REVIEW ARTICLE

L-asparaginase in the treatment of patients with acute lymphoblastic leukemia

Egler Rachel A, Ahuja Sanjay P, Matloub Yousif

Year : 2016| Volume: 7| Issue : 2 | Page no: 62-71

   This article has been cited by
 
1 Characterizing academic performance in pediatric acute lymphoblastic leukemia with population-based achievement tests
Hend M. Al-Kaylani, Erin E. Reasoner, Bradley T. Loeffler, Sarah L. Mott, Susan Madasu, Audrey Liu, Kathleen Langbehn, Amy L. Conrad, David Dickens, Amanda Grafft, Lyndsay Harshman, Arunkumar J. Modi, Ellen van der Plas
Cancer Reports. 2021;
[Pubmed]  [Google Scholar] [DOI]
2 Population Pharmacokinetic Model Development and Simulation for Recombinant Erwinia Asparaginase Produced in Pseudomonas fluorescens (JZP-458)
Tong Lin, Todd Dumas, Josh Kaullen, N. Seth Berry, Mi Rim Choi, Katie Zomorodi, Jeffrey A. Silverman
Clinical Pharmacology in Drug Development. 2021;
[Pubmed]  [Google Scholar] [DOI]
3 Engineered asparaginase from Erwinia chrysanthemi enhances asparagine hydrolase activity and diminishes enzyme immunoreactivity - a new promise to treat acute lymphoblastic leukemia
Iris Munhoz Costa, Débora Custódio Moura, Guilherme Meira Lima, Adalberto Pessoa, Camila Oresco dos Santos, Marcos A Oliveira, Gisele Monteiro
Journal of Chemical Technology & Biotechnology. 2021;
[Pubmed]  [Google Scholar] [DOI]
4 Cancer incidence and survival trends among infants in the United States from 1975 to 2014
Haijun Wang, Maria Carmenza Mejia, Sandra J. Gonzalez, Roger J. Zoorob, Weiwen Chai, Xianglin L. Du
Pediatric Blood & Cancer. 2021; 68(4)
[Pubmed]  [Google Scholar] [DOI]
5 Can recombinant technology address asparaginase Erwinia chrysanthemi shortages?
Luke Maese, Carmelo Rizzari, Russell Coleman, Austin Power, Inge Sluis, Rachel E. Rau
Pediatric Blood & Cancer. 2021; 68(10)
[Pubmed]  [Google Scholar] [DOI]
6 Protease Enzymes: Highlights on Potential of Proteases as Therapeutics Agents
Ravi Shankar, Prabhat Kumar Upadhyay, Manish Kumar
International Journal of Peptide Research and Therapeutics. 2021; 27(2): 1281
[Pubmed]  [Google Scholar] [DOI]
7 Residual biomass from surfactin production is a source of arginase and adsorbed surfactin that is useful for environmental remediation
Thais de Carvalho Silveira, Wyllerson Evaristo Gomes, Giovana Chinaglia Tonon, Thainá Godoy Beatto, Nicolas Spogis, Luiz Henrique Dallan Cunha, Bruno Pera Lattaro, Alessandra Borin Nogueira, Renata Kelly Mendes, Danillo Oliveira Alvarenga, Augusto Etchegaray
World Journal of Microbiology and Biotechnology. 2021; 37(7)
[Pubmed]  [Google Scholar] [DOI]
8 Impact of acute lymphoblastic leukemia induction therapy: findings from metabolomics on non-fasted plasma samples from a biorepository
Toshie Saito, Yue Wei, Li Wen, Chaitanya Srinivasan, Benjamin O. Wolthers, Cheng-Yu Tsai, Marian H. Harris, Kristen Stevenson, Craig Byersdorfer, Judy-April Oparaji, Christian Fernandez, Amitava Mukherjee, Maisam Abu-El-Haija, Sameer Agnihotri, Kjeld Schmiegelow, Megan R. Showalter, Paul W. Fogle, Scott McCulloch, Kevin Contrepois, Lewis B. Silverman, Ying Ding, Sohail Z. Husain
Metabolomics. 2021; 17(7)
[Pubmed]  [Google Scholar] [DOI]
9 Asparaginase-Associated Pancreatitis in Pediatric Patients with Acute Lymphoblastic Leukemia: Current Perspectives
Amber Gibson, Carlos Hernandez, Fiorela N. Hernandez Tejada, Jitesh Kawedia, Michael Rytting, Branko Cuglievan
Pediatric Drugs. 2021; 23(5): 457
[Pubmed]  [Google Scholar] [DOI]
10 Improvement in extracellular secretion of recombinant l-asparaginase II by Escherichia coli BL21 (DE3) using glycine and n-dodecane
Juan Carlos Flores-Santos, Ignacio S. Moguel, Gisele Monteiro, Adalberto Pessoa, Michele Vitolo
Brazilian Journal of Microbiology. 2021; 52(3): 1247
[Pubmed]  [Google Scholar] [DOI]
11 Optimizing use of L-asparaginase–based treatment of adults with acute lymphoblastic leukemia
Dan Douer, Nicola Gökbuget, Wendy Stock, Nicolas Boissel
Blood Reviews. 2021; : 100908
[Pubmed]  [Google Scholar] [DOI]
12 Harnessing the Co-vulnerabilities of Amino Acid-Restricted Cancers
Gaurav Pathria, Ze’ev A. Ronai
Cell Metabolism. 2021; 33(1): 9
[Pubmed]  [Google Scholar] [DOI]
13 Microbial therapeutic enzymes: A promising area of biopharmaceuticals
Meenakshi Vachher, Aparajita Sen, Rachna Kapila, Arti Nigam
Current Research in Biotechnology. 2021; 3: 195
[Pubmed]  [Google Scholar] [DOI]
14 Glutamate - A multifaceted molecule: Endogenous neurotransmitter, controversial food additive, design compound for anti-cancer drugs. A critical appraisal
Octavia-Laura Moldovan, Aura Rusu, Corneliu Tanase, Camil-Eugen Vari
Food and Chemical Toxicology. 2021; 153: 112290
[Pubmed]  [Google Scholar] [DOI]
15 Allergic reactions to asparaginase: retrospective cohort study in pediatric patients with acute lymphoid leukemia
Ana Paula Battistel, Bruno Simas da Rocha, Maitę Telles dos Santos, Liane Esteves Daudt, Mariana Bohns Michalowski
Hematology, Transfusion and Cell Therapy. 2021; 43(1): 9
[Pubmed]  [Google Scholar] [DOI]
16 Molecular dynamics simulations of human L-asparaginase1: Insights into structural determinants of enzymatic activity
Ana Virginia Frota Guimarăes, Natália Fernandes Frota, Marcos Roberto Lourenzoni
Journal of Molecular Graphics and Modelling. 2021; 109: 108007
[Pubmed]  [Google Scholar] [DOI]
17 Human Leucocyte Antigen alleles associated with asparaginase hypersensitivity in childhood Acute Lymphoblastic Leukemia patients treated with Pegylated asparaginase within Dana Farber Cancer Institute treatment protocols
Maria Kondyli, David-Étienne Tremblay, Aziz Rezgui, Sophie Annaelle Serfaty, Vincent Gagné, Maďté Ribčre, Caroline Laverdičre, Jean-Marie Leclerc, Thai Hoa Tran, Daniel Sinnett, Maja Krajinovic
Leukemia Research. 2021; 109: 106650
[Pubmed]  [Google Scholar] [DOI]
18 Isotope tracing reveals glycolysis and oxidative metabolism in childhood tumors of multiple histologies
Kendra Johnston, Panayotis Pachnis, Alpaslan Tasdogan, Brandon Faubert, Lauren G. Zacharias, Hieu Sy Vu, Laurie Rodgers-Augustyniak, Allison Johnson, Fang Huang, Sean Ricciardo, Zhiyu Zhao, Thomas P. Mathews, Tanya Watt, Patrick Leavey, Ralph J. DeBerardinis
Med. 2021; 2(4): 395
[Pubmed]  [Google Scholar] [DOI]
19 A pan-cancer transcriptomic study showing tumor specific alterations in central metabolism
Ilir Sheraj, N. Tulin Guray, Sreeparna Banerjee
Scientific Reports. 2021; 11(1)
[Pubmed]  [Google Scholar] [DOI]
20 Optimisation of physical parameters pH and temperature for maximised activity and stability of Vibrio cholerae L-asparaginase by statistical experimental design
Remya Radha, Sathyanarayana N. Gummadi
Indian Chemical Engineer. 2021; 63(4): 425
[Pubmed]  [Google Scholar] [DOI]
21 L-asparaginase from Dickeya chrysanthemi: expression, purification and cytotoxicity assessment
Hesham Saeed, Eman Elsawy, Manal Shalaby, Manal Abdel-Fattah, Asmaa Hemida, Ahmad Eldoksh, Farid Shokry Ataya, Hesham Nematalla, Mohamed Elkewedi, Nikolaos N. Labrou, Nefertiti El-Nikhely
Preparative Biochemistry & Biotechnology. 2021; : 1
[Pubmed]  [Google Scholar] [DOI]
22 A Randomized Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Recombinant Erwinia Asparaginase (JZP-458) in Healthy Adult Volunteers
Tong Lin, Martha Hernandez-Illas, Andres Rey, Jack Jenkins, Reddy Chandula, Jeffrey A. Silverman, Mi Rim Choi
Clinical and Translational Science. 2021; 14(3): 870
[Pubmed]  [Google Scholar] [DOI]
23 Structural and biochemical properties of L-asparaginase
Jacek Lubkowski, Alexander Wlodawer
The FEBS Journal. 2021; 288(14): 4183
[Pubmed]  [Google Scholar] [DOI]
24 MAPK signaling regulates c-MYC for melanoma cell adaptation to asparagine restriction
Gaurav Pathria, Sachin Verma, Jun Yin, David A Scott, Ze’ev A Ronai
EMBO reports. 2021; 22(3)
[Pubmed]  [Google Scholar] [DOI]
25 Clinical Utility of Pegaspargase in Children, Adolescents and Young Adult Patients with Acute Lymphoblastic Leukemia: A Review
Cynthia Bender, Luke Maese, Maria Carter-Febres, Anupam Verma
Blood and Lymphatic Cancer: Targets and Therapy. 2021; Volume 11: 25
[Pubmed]  [Google Scholar] [DOI]
26 Long-Term Effects of Pediatric Acute Lymphoblastic Leukemia Chemotherapy: Can Recent Findings Inform Old Strategies?
Zeina N. Al-Mahayri, Mohammad M. AlAhmad, Bassam R. Ali
Frontiers in Oncology. 2021; 11
[Pubmed]  [Google Scholar] [DOI]
27 Case Report: The Use of Intravenous SMOFlipid Infusion to Treat Severe Asparaginase-Induced Hypertriglyceridemia in Two Pediatric Acute Lymphoblastic Leukemia Patients
Sie Chong Doris Lau, C-Khai Loh, Hamidah Alias
Frontiers in Pediatrics. 2021; 9
[Pubmed]  [Google Scholar] [DOI]
28 The Neglected Liaison: Targeting Cancer Cell Metabolic Reprogramming Modifies the Composition of Non-Malignant Populations of the Tumor Microenvironment
Maria Iorio, Nikkitha Umesh Ganesh, Monica De Luise, Anna Maria Porcelli, Giuseppe Gasparre, Ivana Kurelac
Cancers. 2021; 13(21): 5447
[Pubmed]  [Google Scholar] [DOI]
29 1-C Metabolism—Serine, Glycine, Folates—In Acute Myeloid Leukemia
Kanwal Mahmood, Ashkan Emadi
Pharmaceuticals. 2021; 14(3): 190
[Pubmed]  [Google Scholar] [DOI]
30 L-Lysine a-Oxidase: Enzyme with Anticancer Properties
Elena V. Lukasheva, Gulalek Babayeva, Saida Sh. Karshieva, Dmitry D. Zhdanov, Vadim S. Pokrovsky
Pharmaceuticals. 2021; 14(11): 1070
[Pubmed]  [Google Scholar] [DOI]
31 Pediatric-inspired regimen with late intensification and increased dose of L-asparaginase for adult acute lymphoblastic leukemia: the KALLA 1406/1407 study
Dong Won Baek, Dae Young Kim, Sang Kyun Sohn, Youngil Koh, Sung-Hoon Jung, Ho-Young Yhim, Yunsuk Choi, Joon Ho Moon
The Korean Journal of Internal Medicine. 2021; 36(6): 1471
[Pubmed]  [Google Scholar] [DOI]
32 L-Asparaginase-Induced Hepatotoxicity Treated Successfully With L-Carnitine and Vitamin B Infusion
Christina Lee, Thomas M Leventhal, Chimaobi M Anugwom
Cureus. 2021;
[Pubmed]  [Google Scholar] [DOI]
33 Microbial endophytes: an untapped resource with antitumor and anti-microbial properties
Preetinder Kaur, Gurpreet Kaur
The Applied Biology & Chemistry Journal. 2020; : 9
[Pubmed]  [Google Scholar] [DOI]
34 Isoferulic acid inhibits human leukemia cell growth through induction of G2/M-phase arrest and inhibition of Akt/mTOR signaling
Zhiguo Long, Guangjia Feng, Na Zhao, Lei Wu, Hongbo Zhu
Molecular Medicine Reports. 2020;
[Pubmed]  [Google Scholar] [DOI]
35 Systems Virology and Human Cytomegalovirus: Using High Throughput Approaches to Identify Novel Host-Virus Interactions During Lytic Infection
Chen-Hsuin Lee, Finn Grey
Frontiers in Cellular and Infection Microbiology. 2020; 10
[Pubmed]  [Google Scholar] [DOI]
36 Positron Emission Tomography for Response Evaluation in Microenvironment-Targeted Anti-Cancer Therapy
Noboru Oriuchi, Shigeyasu Sugawara, Tohru Shiga
Biomedicines. 2020; 8(9): 371
[Pubmed]  [Google Scholar] [DOI]
37 Targeting Protein Synthesis in Colorectal Cancer
Stefanie Schmidt, Sarah Denk, Armin Wiegering
Cancers. 2020; 12(5): 1298
[Pubmed]  [Google Scholar] [DOI]
38 HLA alleles associated with asparaginase hypersensitivity in childhood ALL: a report from the DFCI Consortium
Vincent Gagné, Pascal St-Onge, Patrick Beaulieu, Caroline Laverdičre, Jean-Marie Leclerc, Thai H Tran, Stephen E Sallan, Donna Neuberg, Lewis B Silverman, Daniel Sinnett, Maja Krajinovic
Pharmacogenomics. 2020; 21(8): 541
[Pubmed]  [Google Scholar] [DOI]
39 Targeting metabolic dependencies in pediatric cancer
Sameer H. Issaq, Christine M. Heske
Current Opinion in Pediatrics. 2020; 32(1): 26
[Pubmed]  [Google Scholar] [DOI]
40 Correlation of L-asp Activity, Anti-L-asp Antibody, Asn and Gln With Adverse Events Especially Anaphylaxis Risks in PEG-asp-Contained Regime Treated Pediatric ALL Patients
Juan Wu, Changcheng Chen, Shiying Huang, Shuhong Shen, Jing Chen, Shunguo Zhang
Technology in Cancer Research & Treatment. 2020; 19: 1533033820
[Pubmed]  [Google Scholar] [DOI]
41 Nutrient metabolism and cancer in the in vivo context: a metabolic game of give and take
Patricia Altea-Manzano, Alejandro M Cuadros, Lindsay A Broadfield, Sarah-Maria Fendt
EMBO reports. 2020; 21(10)
[Pubmed]  [Google Scholar] [DOI]
42 Concurrent use of rabacfosadine and L-asparaginase for relapsed or refractory multicentric lymphoma in dogs
Jacob R. Cawley, Zachary M. Wright, Karri Meleo, Gerald S. Post, Craig A. Clifford, Kathryn R. Vickery, David M. Vail, Philip J. Bergman, Douglas H. Thamm
Journal of Veterinary Internal Medicine. 2020; 34(2): 882
[Pubmed]  [Google Scholar] [DOI]
43 Bilateral breast masses as a presentation for T-cell acute lymphoblastic leukaemia
Osama Mosalem, Fawzi Abu Rous, Ahmed Elshafie, Daniel Isaac
BMJ Case Reports. 2020; 13(8): e236263
[Pubmed]  [Google Scholar] [DOI]
44 Space for Calaspargase? A New Asparaginase for Acute Lymphoblastic Leukemia
Glen Lew
Clinical Cancer Research. 2020; 26(2): 325
[Pubmed]  [Google Scholar] [DOI]
45 Critical overview of the main features and techniques used for the evaluation of the clinical applicability of L-asparaginase as a biopharmaceutical to treat blood cancer
T.A. Costa-Silva, I.M. Costa, H.P. Biasoto, G.M. Lima, C. Silva, A. Pessoa, G. Monteiro
Blood Reviews. 2020; 43: 100651
[Pubmed]  [Google Scholar] [DOI]
46 Study of L-Asparaginase, Vincristine, and Dexamethasone Combined With Intensity-modulated Radiation Therapy in Early-Stage Nasal NK/T-Cell Lymphoma
Yunfei Hu, Mengxiang Chen, Yang Song, Xiaomei Liu, Feng Gou, Jing Zhang, Yunhong Huang
American Journal of Clinical Oncology. 2020; 43(4): 257
[Pubmed]  [Google Scholar] [DOI]
47 Thromboembolism prophylaxis during L-asparaginase therapy in acute lymphoblastic leukemia – time to reconsider current approaches?
J. Fulcher, M. Carrier
Thrombosis Research. 2020; 188: 100
[Pubmed]  [Google Scholar] [DOI]
48 Mechanism of Catalysis by l-Asparaginase
Jacek Lubkowski, Juan Vanegas, Wai-Kin Chan, Philip L. Lorenzi, John N. Weinstein, Sergei Sukharev, David Fushman, Susan Rempe, Andriy Anishkin, Alexander Wlodawer
Biochemistry. 2020; 59(20): 1927
[Pubmed]  [Google Scholar] [DOI]
49 Spatial modeling of prostate cancer metabolic gene expression reveals extensive heterogeneity and selective vulnerabilities
Yuliang Wang, Shuyi Ma, Walter L. Ruzzo
Scientific Reports. 2020; 10(1)
[Pubmed]  [Google Scholar] [DOI]
50 Immunogenicity assessment of fungal l-asparaginases: an in silico approach
Lisandra Herrera Belén, Jorge F. Beltrán Lissabet, Carlota de Oliveira Rangel-Yagui, Gisele Monteiro, Adalberto Pessoa, Jorge G. Farías
SN Applied Sciences. 2020; 2(2)
[Pubmed]  [Google Scholar] [DOI]
51 Optimization of aqueous two-phase micellar system for partial purification of L-asparaginase from Penicillium sp. grown in wheat bran as agro-industrial residue
Samuel L. Cardoso, Marcela M. de Freitas, Paula M. de Souza, Mauricio Homem-de-Mello, Dâmaris Silveira, Yris Maria Fonseca-Bazzo, Edivaldo X. Filho, Adalberto P. Junior, Pérola O. Magalhăes
Brazilian Journal of Microbiology. 2020; 51(3): 979
[Pubmed]  [Google Scholar] [DOI]
52 Toxicity Analysis of Recombinant L-asparaginase I and II in Zebrafish
Susan Aishwarya Suresh, Selvarajan Ethiraj, K. N. Rajnish
Indian Journal of Microbiology. 2020; 60(4): 535
[Pubmed]  [Google Scholar] [DOI]
53 A comprehensive review on microbial l -asparaginase: Bioprocessing, characterization, and industrial applications
Subhash Chand, Richi V. Mahajan, Jai Prakash Prasad, Debendra K. Sahoo, Kanti Nandan Mihooliya, Mahesh S. Dhar, Girish Sharma
Biotechnology and Applied Biochemistry. 2020; 67(4): 619
[Pubmed]  [Google Scholar] [DOI]
54 Lysine oxidase exposes a dependency on the thioredoxin antioxidant pathway in triple-negative breast cancer cells
Olga E. Chepikova, Dmitry Malin, Elena Strekalova, Elena V. Lukasheva, Andrey A. Zamyatnin, Vincent L. Cryns
Breast Cancer Research and Treatment. 2020; 183(3): 549
[Pubmed]  [Google Scholar] [DOI]
55 Microbial enzymes for deprivation of amino acid metabolism in malignant cells: biological strategy for cancer treatment
Rakhi Dhankhar, Vatika Gupta, Sanjay Kumar, Rajeev Kumar Kapoor, Pooja Gulati
Applied Microbiology and Biotechnology. 2020; 104(7): 2857
[Pubmed]  [Google Scholar] [DOI]
56 Inhibitory and Stimulatory Effects of Some Metals on Asparaginase Activity Produced by Staphylococcus MGM1
Mahtab Ghorbanmovahed, Gholamhossein Ebrahimipour, Abdolrazagh Marzban
Iranian Journal of Medical Microbiology. 2019; 13(5): 374
[Pubmed]  [Google Scholar] [DOI]
57 Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma
G K Abou-Alfa,S Qin,B-Y Ryoo,S-N Lu,C-J Yen,Y-H Feng,H Y Lim,F Izzo,M Colombo,D Sarker,L Bolondi,G Vaccaro,W P Harris,Z Chen,R A Hubner,T Meyer,W Sun,J J Harding,E M Hollywood,J Ma,P J Wan,M Ly,J Bomalaski,A Johnston,C-C Lin,Y Chao,L-T Chen
Annals of Oncology. 2018;
[Pubmed]  [Google Scholar] [DOI]
58 Improving the Efficiency of V?9Vd2 T-Cell Immunotherapy in Cancer
Timm Hoeres,Manfred Smetak,Dominik Pretscher,Martin Wilhelm
Frontiers in Immunology. 2018; 9
[Pubmed]  [Google Scholar] [DOI]
59 Small Molecule Catalysts with Therapeutic Potential
Yannick Ney,Muhammad Jawad Nasim,Ammar Kharma,Lama Youssef,Claus Jacob
Molecules. 2018; 23(4): 765
[Pubmed]  [Google Scholar] [DOI]
60 Engineering l-asparaginase for spontaneous formation of calcium phosphate bioinspired microreactors
Alexandra Louka,Irina Matlahov,Stefano Giuntini,Linda Cerofolini,Andrea Cavallo,Serena Pillozzi,Enrico Ravera,Marco Fragai,Annarosa Arcangeli,Ayyalusamy Ramamoorthy,Gil Goobes,Claudio Luchinat
Physical Chemistry Chemical Physics. 2018;
[Pubmed]  [Google Scholar] [DOI]
61 Microbial cell disruption methods for efficient release of enzyme L-asparaginase
Tales A. Costa-Silva,Juan Carlos Flores-Santos,Rominne K. B. Freire,Michele Vitolo,Adalberto Pessoa-Jr
Preparative Biochemistry and Biotechnology. 2018; : 1
[Pubmed]  [Google Scholar] [DOI]
62 Levocarnitine and vitamin B complex for the treatment of pegaspargase-induced hepatotoxicity: A case report and review of the literature
Alison Blackman,Alyssa Boutin,Alexei Shimanovsky,William J Baker,Nicholas Forcello
Journal of Oncology Pharmacy Practice. 2018; 24(5): 393
[Pubmed]  [Google Scholar] [DOI]
63 Efficacy and safety of recombinant E. coli asparaginase in children with previously untreated acute lymphoblastic leukemia: A randomized multicenter study of the Dutch Childhood Oncology Group
Inge M. van der Sluis,Hester de Groot-Kruseman,Maroeska te Loo,Wim J.E. Tissing,Cor van den Bos,Gertjan J.L. Kaspers,Marc Bierings,Wouter J.W. Kollen,Thorsten König,Uwe Pichlmeier,Hans-Jürgen Kühnel,Rob Pieters
Pediatric Blood & Cancer. 2018; : e27083
[Pubmed]  [Google Scholar] [DOI]
64 Expression and Functional Characterization of Pseudomonas aeruginosa Recombinant l.Asparaginase
Hesham Saeed,Hadeer Soudan,Amany El-Sharkawy,Aida Farag,Amira Embaby,Farid Ataya
The Protein Journal. 2018;
[Pubmed]  [Google Scholar] [DOI]
65 Survival analysis of adult patients with ALL in Mexico City: first report from the Acute Leukemia Workgroup (ALWG) (GTLA)
Erick Crespo-Solis,Karla Espinosa-Bautista,Martha Alvarado-Ibarra,Etta Rozen-Fuller,Fernando Pérez-Rocha,Chantal Nava-Gómez,Maricela Ortiz-Zepeda,José Luis Álvarez-Vera,Christian Omar Ramos-Peńafiel,Luis Antonio Meillón-García,Sergio Rodríguez-Rodríguez,Alan Pomerantz-Okon,Francisco Javier Turrubiates-Hernández,Roberta Demichelis-Gómez
Cancer Medicine. 2018;
[Pubmed]  [Google Scholar] [DOI]
66 Marine microbial L-asparaginase: Biochemistry, molecular approaches and applications in tumor therapy and in food industry
Fatemeh Izadpanah Qeshmi,Ahmad Homaei,Pedro Fernandes,Sedigheh Javadpour
Microbiological Research. 2018; 208: 99
[Pubmed]  [Google Scholar] [DOI]
67 Perforated jejunitis in a child with acute lymphoblastic leukemia treated with pegaspargase
Elizabeth R. Tang,Teresa Chapman,Laura S. Finn,Kasey J. Leger
Radiology Case Reports. 2018; 13(3): 568
[Pubmed]  [Google Scholar] [DOI]
68 Glutaminase free l -asparaginase from Vibrio cholerae : Heterologous expression, purification and biochemical characterization
Remya Radha,Nagarajan Arumugam,Sathyanarayana N. Gummadi
International Journal of Biological Macromolecules. 2018;
[Pubmed]  [Google Scholar] [DOI]
69 Metabolic regulation of hematopoietic and leukemic stem/progenitor cells under homeostatic and stress conditions
Daiki Karigane,Keiyo Takubo
International Journal of Hematology. 2017; 106(1): 18
[Pubmed]  [Google Scholar] [DOI]
70 Targeting Metabolism for Cancer Therapy
Alba Luengo,Dan Y. Gui,Matthew G. Vander Heiden
Cell Chemical Biology. 2017; 24(9): 1161
[Pubmed]  [Google Scholar] [DOI]
71 Similarities and Distinctions of Cancer and Immune Metabolism in Inflammation and Tumors
Gabriela Andrejeva,Jeffrey C. Rathmell
Cell Metabolism. 2017; 26(1): 49
[Pubmed]  [Google Scholar] [DOI]
72 Rhodospirillum rubrum l -asparaginase targets tumor growth by a dual mechanism involving telomerase inhibition
Dmitry D. Zhdanov,Vadim S. Pokrovsky,Marina V. Pokrovskaya,Svetlana S. Alexandrova,Mikhail A. Eldarov,Dmitry V. Grishin,Marsel M. Basharov,Yulia A. Gladilina,Olga V. Podobed,Nikolai N. Sokolov
Biochemical and Biophysical Research Communications. 2017; 492(2): 282
[Pubmed]  [Google Scholar] [DOI]
73 Treatment of Young Adults with Acute Lymphoblastic Leukemia
Ankit Kansagra,Mark Litzow
Current Hematologic Malignancy Reports. 2017;
[Pubmed]  [Google Scholar] [DOI]
74 Asparaginase pharmacology: challenges still to be faced
Claudia Lanvers-Kaminsky
Cancer Chemotherapy and Pharmacology. 2017;
[Pubmed]  [Google Scholar] [DOI]
75 Therapeutic Drug Monitoring of Asparaginase Activity - Method Comparison of MAATTM and AHA Test Used in the International AIEOP-BFM ALL 2009 Trial
Claudia Lanvers-Kaminsky,Andrea Rüffer,Gudrun Würthwein,Joachim Gerss,Massimo Zucchetti,Andrea Ballerini,Andishe Attarbaschi,Petr Smisek,Christa Nath,Samiuela Lee,Sara Elitzur,Martin Zimmermann,Anja Möricke,Martin Schrappe,Carmelo Rizzari,Joachim Boos
Therapeutic Drug Monitoring. 2017; : 1
[Pubmed]  [Google Scholar] [DOI]
76 L-Asparaginase for newly diagnosed extra-nodal NK/T-cell lymphoma: systematic review and meta-analysis
Vadim S. Pokrovsky,Denis Vinnikov
Expert Review of Anticancer Therapy. 2017; : 1
[Pubmed]  [Google Scholar] [DOI]
77 Pharmacogenomics in pediatric acute lymphoblastic leukemia: promises and limitations
Zeina N Al-Mahayri,George P Patrinos,Bassam R Ali
Pharmacogenomics. 2017; 18(7): 687
[Pubmed]  [Google Scholar] [DOI]
78 Emerging biological therapies to treat acute lymphoblastic leukemia
Françoise Huguet,Suzanne Tavitian
Expert Opinion on Emerging Drugs. 2016; : 1
[Pubmed]  [Google Scholar] [DOI]

 

Read this article